- Show all
- 1557
- 50th Anniversary
- Abortion
- Admin and Procedural Barriers
- ADS Evergreen
- Affordable Care Act
- Assisted Reproduction
- Automated Decision Making
- Behavioral Health
- Child and Adolescent Health
- CHIP
- Civil Procedure
- Civil Rights
- Coronavirus
- Cost-sharing
- Court Access
- COVID-19 Public Health Emergency
- Data Collection
- Defending Medicaid
- Delivery System Featured
- Delivery System Reform
- Demonstrations
- Disability
- Disability Rights
- Doula Care
- Dual Eligible Beneficiaries
- Eligibility and Enrollment
- EPSDT
- Exchanges/Marketplaces
- Family Planning
- Federal and State Court Cases
- Foster youth
- HCBS/LTSS
- Health Care Reform
- Health Care Refusals
- Health Disparities
- Health Reform
- HIV/AIDS and Sexual Health
- Home and Community Based Services
- Immigrant Health
- Language Access
- LGBTQ Health
- Litigation
- Managed Care
- Medi-Cal
- Medicaid
- Medicaid Awareness Month
- Medicaid Awareness Month 2024
- Mental Health
- Nondiscrimination
- Opioid Use Disorder
- Oral Health
- Pregnancy
- Prescription Drugs Marketplace
- Prescription Drugs Medicaid
- Privacy and Confidentiality
- Protect Medicaid 2023
- Public Charge
- Public Health
- Refusals of SRH Care
- Reproductive Health
- Services
- Sexual and Reproductive Health (SRH)
- Sexual Health
- SRH Equity
- SRH Equity for Immigrants
- SRH Equity for LGBTQI+ People
- SRH Equity for People of Color
- SRH Equity for People with Disabilities
- SRH Equity for Young People
- SRH Nondiscrimination
- Supreme Court
- Telehealth
- Waivers and Demonstrations
- Women's Health
- September 17, 2020
NHeLP comments on Approved Drug Products with Therapeutic Equivalence Evaluations (the “Orange Book”)
Read moreThe Orange Book is an important and informative drug resource for a range of stakeholders. In a request for comments, FDA seeks feedback on the types of people or entitles using the Orange Book, additional information and features to incorporate into the Orange Book, and therapeutic equivalence information. NHeLP…
- September 14, 2020
NHeLP comments on HHS Proposed Rule on Guidance
Read moreGuidance documents are a valuable tool that allows agencies to clarify policy issues and explain ambiguities raised by the laws and rules they are tasked with implementing. Programs like Medicaid and the implementation of the Affordable Care Act depend heavily on guidance documents to clarify coverage requirements and the…
- August 11, 2020
The Maintenance of Effort Provision Protects Services
Read moreThe Families First maintence of effort provision not only prohibits states from disenrolling individuals, but it ensures that services available to enrollees at the start of the pandemic remain available to them as long as the state is receiving the enhanced match. At a time when many doctors’ offices…
- July 29, 2020
COVID-19 Litigation Docket
Read moreThe COVID-19 pandemic has resulted in rapid and significant changes to the country’s health care system. State Medicaid programs, state insurance departments, and the federal government have responded in a variety of ways. This docket tracks state and federal litigation stemming from the COVID-19 response and relating to Medicaid,…
- July 20, 2020
Top Ten List: Medicaid Eligibility & Enrollment in Light of COVID-19
Read moreThis publication identifies ten actions that advocates can take to maximize eligibility and enrollment in Medicaid during and after the COVID-19 emergency.
- July 20, 2020
NHeLP comments on Medicaid Prescrption Drug Rebate Program and Value- based Purchasing Proposed Rulemaking
Read moreIn a proposed rule, CMS seeks to expand value-based purchasing arrangements for prescription drugs in commercial plans and the Medicaid program. However, the proposed changes offer a cost-containment strategy with no safeguards to ensure that Medicaid enrollees can continue to access needed outpatient prescription drugs. NHeLP comments warn against“cost…
